JPRN-UMIN000005248已完成2 期
WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical study - Advanced pancreatic cancer GEM+WT1 vaccine RCT P2
Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine0 个研究点目标入组 150 人开始时间: 2011年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Simultaneous or metachronous (within 5 years) double cancers, with exception of intramucosal tumor curable with local therapy 2) Pregnant or lactating women or women fo childearing potential, and men who want to get partner pregnat 3) Psychosis 4) Patients requiring systemic immunosuppresive agents, or moderate or higher dose of steroid with exception of usage for cancer pain 5) Pulmonary fibrosis or interstitial pneumonitis 6) Active bacterial or fungal infection 7) Severe complications 8) MDS, MDS/MPD, MPD 9) Severe drug allergy 10) Inadequate physical condition, as diagnosed by the primary physician
研究者
相似试验
招募中
不适用
WT1 peptide-based cancer vaccine for long-term maintenance of anti-tumor immunitysolid tumor, malignant lymphoma, acute leukemiaJPRN-UMIN000015997Osaka University Graduate Shool of Medicine, Functional Diagnostic Science56
尚未招募
2 期
WT1 peptide-based cancer vaccine in patients with high risk rhabdomyosarcoma, a multicenter, phase 2 clinical studyrhabdomyosarcomaJPRN-UMIN000013325Osaka university graduate school of medicine Pediatrics33
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001187Department of Cancer immunotherapy, Osaka University Medical School18
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancerJPRN-UMIN000001209Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine18
已完成
1 期
WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancersadvanced pancreatic and biliary tract cancersJPRN-UMIN000004081Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine20